Researchers translate a hypothesis into a personalized treatment for cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Arch Biopartners Receives Permission From U S FDA to Proceed With Phase II Acute Kidney Injury Trial tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
07.02.2023 - TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) - Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting .